Skip to main content
. 2015 Oct 16;53(11):3646–3649. doi: 10.1128/JCM.02303-15

TABLE 3.

Percentage of 2-fold dilution differences between the agar dilution modal MICs and the Etest modal MICs for proficiency panel isolates between 2003 and 2012

Antibiotic No. of isolatesa No. of results (agar/Etest)b % isolates (agar dilution modal MIC − Etest modal MIC) that differ by the following no. of 2-fold dilutions
% agreement of modal MICs Matched-pair t test, P < 0.05 of modal MIC means
% concordance of interpretations Modal MICs at categorical interpretation breakpointsc
≤−2 −1 Same 1 ≥2 t P Significant % No.
Penicillin 74 400/554 4.1 35.1 55.4 5.4 0.0 96.0 1.96 0.09525 No 94.5 43.6 34/78
Tetracycline 82 433/586 15.9 69.5 13.4 1.2 0.0 84.1 5.20 <0.00001 Yes 79.3 67.9 57/84
Erythromycin 30 252/260 0.0 56.7 40.0 3.3 0.0 100.0 −0.45 0.65312 No 69.6 73.3 22/30
Spectinomycin 66 324/314 3.0 42.4 53.0 1.5 0.0 97.0 −0.15 0.87878 No 100.0 34.8 23/66
Ceftriaxone 90 398/641 3.3 35.6 52.2 8.9 0.0 96.7 4.27 0.00005 Yes 93.9 26.7 24/90
Ciprofloxacin 80 403/545 1.3 43.8 47.5 7.5 0.0 98.8 −1.52 0.13336 No 93.2 27.5 22/80
Cefixime 27 272/310 0.0 40.7 51.9 7.4 0.0 100.0 2.39 0.02457 Yes 94.9 31.4 11/35
Azithromycin 62 275/626 0.0 12.9 71.0 16.1 0.0 100.0 −0.04 0.96567 No 95.6 25.8 16/62
a

Number of isolates that have modal MICs for both the agar dilution method and the Etest method and can therefore be compared.

b

Total number of MIC values used to determine the modal MICs for both the agar dilution method and the Etest method.

c

The numbers of modal MICs at breakpoints for both Etest and agar dilution were calculated. The highest number of the 2 calculations was used.